Malignant Peritoneal Neoplasm Recruiting Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02873962A Phase II Study Of Nivolumab/ Bevacizumab/RucaparibTreatment